Predicting tumor recurrence in patients with cervical carcinoma treated with definitive chemoradiotherapy: value of quantitative histogram analysis on diffusion-weighted MR images
- PMID: 27445314
- DOI: 10.1177/0284185116656492
Predicting tumor recurrence in patients with cervical carcinoma treated with definitive chemoradiotherapy: value of quantitative histogram analysis on diffusion-weighted MR images
Abstract
Background Further research is required for evaluating the use of ADC histogram analysis in more advanced stages of cervical cancer treated with definitive chemoradiotherapy (CRT). Purpose To investigate the utility of apparent diffusion coefficient (ADC) histogram derived from diffusion-weighted magnetic resonance images in cervical cancer patients treated with definitive CRT. Material and Methods The clinical and radiological data of 50 patients with histologically proven cervical squamous cell carcinoma treated with definitive CRT were retrospectively analyzed. The impact of clinicopathological factors and ADC histogram parameters on prognostic factors and treatment outcomes was assessed. Results The mean and median ADC values for the cohort were 1.043 ± 0.135 × 10-3 mm2/s and 1.018 × 10-3 mm2/s (range, 0.787-1.443 × 10-3 mm2/s). The mean ADC was significantly lower for patients with advanced stage (≥IIB) or lymph node metastasis compared with patients with stage <IIB or no lymph node metastasis. The mean ADC, 75th percentile ADC (ADC75), 90th percentile ADC (ADC90), and 95th percentile ADC (ADC95) were significantly lower in patients with tumor recurrence compared with patients without recurrence. In multivariate analysis, tumor size, ADC75 and ADC95 were independent prognostic factors for both overall survival and disease-free survival. Conclusion ADC histogram parameters could be markers for disease recurrence and for predicting survival outcomes. ADC75, ADC90, and ADC95 of the primary tumor were significant predictors of disease recurrence in cervical cancer patients treated with definitive CRT.
Keywords: Cervical cancer; apparent diffusion coefficient; chemoradiotherapy; magnetic resonance imaging (MRI); prognostic factor.
Similar articles
-
Treatment response evaluation using the mean apparent diffusion coefficient in cervical cancer patients treated with definitive chemoradiotherapy.J Magn Reson Imaging. 2016 Oct;44(4):1010-9. doi: 10.1002/jmri.25215. Epub 2016 Feb 27. J Magn Reson Imaging. 2016. PMID: 26919800
-
Diffusion-weighted imaging: Apparent diffusion coefficient histogram analysis for detecting pathologic complete response to chemoradiotherapy in locally advanced rectal cancer.J Magn Reson Imaging. 2016 Jul;44(1):212-20. doi: 10.1002/jmri.25117. Epub 2015 Dec 15. J Magn Reson Imaging. 2016. PMID: 26666560 Clinical Trial.
-
Pre-treatment diffusion-weighted MR imaging for predicting tumor recurrence in uterine cervical cancer treated with concurrent chemoradiation: value of histogram analysis of apparent diffusion coefficients.Korean J Radiol. 2013 Jul-Aug;14(4):616-25. doi: 10.3348/kjr.2013.14.4.616. Epub 2013 Jul 17. Korean J Radiol. 2013. PMID: 23901319 Free PMC article.
-
Can Diffusion-weighted Magnetic Resonance Imaging Predict Survival in Patients with Cervical Cancer? A Meta-Analysis.Eur J Radiol. 2016 Dec;85(12):2174-2181. doi: 10.1016/j.ejrad.2016.10.011. Epub 2016 Oct 13. Eur J Radiol. 2016. PMID: 27842663 Review.
-
Pre-treatment Apparent Diffusion Coefficient Does Not Predict Therapy Response to Radiochemotherapy in Cervical Cancer: A Systematic Review and Meta-analysis.Anticancer Res. 2021 Mar;41(3):1163-1170. doi: 10.21873/anticanres.14873. Anticancer Res. 2021. PMID: 33788707
Cited by
-
Magnetic resonance imaging in cervical cancer interventional radiotherapy (brachytherapy): a pictorial essay focused on radiologist management.J Contemp Brachytherapy. 2022 Jun;14(3):287-298. doi: 10.5114/jcb.2022.117727. Epub 2022 Jun 30. J Contemp Brachytherapy. 2022. PMID: 36199994 Free PMC article.
-
The Value of Whole-Tumor Texture Analysis of ADC in Predicting the Early Recurrence of Locally Advanced Cervical Squamous Cell Cancer Treated With Concurrent Chemoradiotherapy.Front Oncol. 2022 May 20;12:852308. doi: 10.3389/fonc.2022.852308. eCollection 2022. Front Oncol. 2022. PMID: 35669419 Free PMC article.
-
Diagnostic Strategies for Recurrent Cervical Cancer: A Cohort Study.Front Oncol. 2020 Dec 7;10:591253. doi: 10.3389/fonc.2020.591253. eCollection 2020. Front Oncol. 2020. PMID: 33365270 Free PMC article.
-
Whole lesion histogram analysis of apparent diffusion coefficients on MRI predicts disease-free survival in locally advanced squamous cell cervical cancer after radical chemo-radiotherapy.BMC Cancer. 2019 Nov 15;19(1):1115. doi: 10.1186/s12885-019-6344-3. BMC Cancer. 2019. PMID: 31729974 Free PMC article.
-
Texture analysis versus conventional MRI prognostic factors in predicting tumor response to neoadjuvant chemotherapy in patients with locally advanced cancer of the uterine cervix.Radiol Med. 2019 Oct;124(10):955-964. doi: 10.1007/s11547-019-01055-3. Epub 2019 Jun 28. Radiol Med. 2019. PMID: 31254220
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials